Adam Fry

Adam Fry possesses extensive experience in clinical science and neurotechnology, serving as Clinical Science Manager at Synchron from August 2022 to January 2024, where responsibilities included leading pre-market trials for endovascular neurotechnology and brain-computer interfaces. Prior to this role, Adam was an Instructor in Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai, focusing on clinical trials for neurotechnology devices. Adam's research contributions include significant work as a Postdoctoral Research Fellow and Research Scientist, with expertise in developing interventions for neurological conditions. Adam holds a PhD in Neurophysiology and a Master's degree in Sports Science from Loughborough University.